Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders Equity (Unaudited) - USD ($)
Total
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Non Controlling Interest [Member]
Common stock [Member]
Balance, shares at Dec. 31, 2018           35,335,378
Balance, amount at Dec. 31, 2018 $ 12,140,456 $ 85,604,271 $ 223,651 $ (73,722,801) $ 0 $ 35,335
Common stock issued in exercise of warrants, shares           2,478,613
Common stock issued in exercise of warrants, amount 6,660,671 6,658,192 0 0 0 $ 2,479
Stock-based compensation 340,458 340,458 0 0 0 0
Modification of financing warrants 196,957 196,957 0 0 0 0
Foreign currency translation (24,054) 0 (24,054) 0   0
Net loss for the period (4,203,773) 0 0 (4,203,773) 0 $ 0
Balance, shares at Mar. 31, 2019           37,813,991
Balance, amount at Mar. 31, 2019 15,110,715 92,799,878 199,597 (77,926,574) 0 $ 37,814
Balance, shares at Dec. 31, 2018           35,335,378
Balance, amount at Dec. 31, 2018 12,140,456 85,604,271 223,651 (73,722,801) 0 $ 35,335
Net loss for the period (12,541,749)          
Balance, shares at Sep. 30, 2019           41,092,340
Balance, amount at Sep. 30, 2019 17,801,780 103,374,419 650,819 (86,264,550) 0 $ 41,092
Balance, shares at Mar. 31, 2019           37,813,991
Balance, amount at Mar. 31, 2019 15,110,715 92,799,878 199,597 (77,926,574) 0 $ 37,814
Common stock issued in exercise of warrants, shares           1,666,667
Common stock issued in exercise of warrants, amount 5,000,001 4,998,334 0 0 0 $ 1,667
Stock-based compensation 379,507 379,507 0 0 0 0
Foreign currency translation 49,913 0 49,913 0 0 0
Net loss for the period (4,157,171) 0 0 (4,157,171) 0 $ 0
Balance, shares at Jun. 30, 2019           39,480,658
Balance, amount at Jun. 30, 2019 16,382,965 98,177,719 249,510 (82,083,745) 0 $ 39,481
Common stock issued in exercise of warrants, shares           1,609,195
Common stock issued in exercise of warrants, amount 4,827,585 4,825,976 0 0 0 $ 1,609
Stock-based compensation 370,726 370,726 0 0 0 0
Foreign currency translation 401,309 0 401,309 0 0 0
Net loss for the period (4,180,805) 0 0 (4,180,805) 0 $ 0
Common stock issued in exercise of stock options, shares           2,487
Common stock issued in exercise of stock options, amount 0 (2) 0 0 0 $ 2
Balance, shares at Sep. 30, 2019           41,092,340
Balance, amount at Sep. 30, 2019 17,801,780 103,374,419 650,819 (86,264,550) 0 $ 41,092
Balance, shares at Dec. 31, 2019           41,125,303
Balance, amount at Dec. 31, 2019 14,198,566 103,853,627 125,670 (89,821,856) 0 $ 41,125
Stock-based compensation 192,669 192,669 0 0 0 0
Foreign currency translation 373,926 0 373,926 0 0 0
Net loss for the period (5,859,339) 0 0 (5,849,772) (9,567) $ 0
Common stock issued in exercise of stock options, shares           19,430
Common stock issued in exercise of stock options, amount 0 (20) 0 0 0 $ 20
Common stock issued for Director compensation in Volition Germany, shares           73,263
Common stock issued for Director compensation in Volition Germany, amount 333,969 333,896 0 0 0 $ 73
Common stock repurchase and retirement, shares           (11,364)
Common stock repurchase and retirement, amount (54,434) (54,423) 0 0 0 $ (11)
Balance, shares at Mar. 31, 2020           41,206,632
Balance, amount at Mar. 31, 2020 9,185,357 104,325,749 499,596 (95,671,628) (9,567) $ 41,207
Balance, shares at Dec. 31, 2019           41,125,303
Balance, amount at Dec. 31, 2019 14,198,566 103,853,627 125,670 (89,821,856) 0 $ 41,125
Net loss for the period (15,238,380)          
Balance, shares at Sep. 30, 2020           48,064,575
Balance, amount at Sep. 30, 2020 18,961,411 124,121,703 (148,121) (105,036,840) (23,396) $ 48,065
Balance, shares at Mar. 31, 2020           41,206,632
Balance, amount at Mar. 31, 2020 9,185,357 104,325,749 499,596 (95,671,628) (9,567) $ 41,207
Stock-based compensation 360,640 360,640 0 0 0 0
Foreign currency translation (74,320) 0 (74,320) 0 0 0
Net loss for the period (5,043,093) 0 0 (5,037,314) (5,779) $ 0
Common stock issued in public offering, net, shares           5,452,922
Common stock issued in public offering, net, amount 14,234,613 14,229,160 0 0 0 $ 5,453
Balance, shares at Jun. 30, 2020           46,659,554
Balance, amount at Jun. 30, 2020 18,663,197 118,915,549 425,276 (100,708,942) (15,346) $ 46,660
Common stock issued in exercise of warrants, shares           25,000
Common stock issued in exercise of warrants, amount 61,750 61,725 0 0 0 $ 25
Stock-based compensation 428,683 428,683 0 0 0 0
Foreign currency translation (573,397) 0 (573,397) 0 0 0
Net loss for the period (4,335,948) 0 0 (4,327,898) (8,050) $ 0
Common stock issued in exercise of stock options, shares           127,838
Common stock issued in exercise of stock options, amount 82,500 82,372 0 0 0 $ 128
Common stock issued in public offering, net, shares           1,252,183
Common stock issued in public offering, net, amount 4,822,091 4,820,839 0 0 0 $ 1,252
Tax withholdings paid related to stock-based compensation (187,465) (187,465) 0 0 0 $ 0
Balance, shares at Sep. 30, 2020           48,064,575
Balance, amount at Sep. 30, 2020 $ 18,961,411 $ 124,121,703 $ (148,121) $ (105,036,840) $ (23,396) $ 48,065